In this one in patients with acute coronary syndrome, reductions in LDL particle electronegativity were linked to alterations of the LDL lipidome, and were associated with all-cause and cardiovascular mortality beyond some established risk factors during a 1-year follow-up.
"In a prospective cohort of contemporary patients with ACS, we demonstrate for the first time that attenuated LDL electronegativity, as assessed by the L1-L5 ratio...
"...unfavorably associates with all-cause and cardiovascular mortality after the index ACS, over and above the updated GRACE risk score...
"...Moreover, our data suggest that the lipidome of LDL particles markedly differs depending on their charge, with the majority of highest-ranked lipid species independently associating with adverse events...
"...Importantly, LDL electronegativity represented the second highest-ranked predictor of all-cause death, and superseded several clinical risk factors for the prediction of cardiovascular death at 1 year...
"...While the exact mechanism underpinning this phenomenon warrants further study...
"...it is interesting to note that electronegative properties of LDL particles determine their LDL-receptor (LDLR) affinity, with changes in LDL charge impinging on their pro-thrombotic and pro-atherogenic effects."
Low-density lipoprotein electronegativity and risk of death after acute coronary syndromes: A case-cohort analysis (open access)
In this one, a higher cardiovascular risk, as assessed by the Framingham 10‐year cardiovascular disease risk score, was associated with poorer cognitive function among older adults living in the US.
- The Framingham 10‐year cardiovascular disease risk score is based on age, sex, smoking, total cholesterol, high‐density lipoprotein‐cholesterol, blood pressure, and diabetes.
- It was found to be associated with lower cognitive function among older adults, including overall cognition and particular domains of cognition, such as executive function and processing speed, and immediate and delayed memory.
In this one, HMB supplementation was associated with improvements in muscle strength, physical performance and muscle quality (defined as the handgrip strength/fat-free mass ratio) in older adults with sarcopenia during a resistance exercise program.
- This randomized, double-blind, placebo-controlled study aimed to evaluate whether HMB supplementation can improve muscle strength, function, and body composition in older adults with sarcopenia.
- This study included subjects aged ≥60 years with sarcopenia which were assigned to the HMB group or the placebo group.
This one found a bidirectional, dose-response relationship between handgrip strength and cognitive function in a multinational, European population with a mean age of 68.42 years.
- This study tried to analyze the longitudinal association between handgrip strength and cognitive performance in different cognitive functions according to sex in a European multicentric population.
- A longitudinal and bidirectional relationship between handgrip strength and three different cognitive functions was observed.
This umbrella review finds that the evidence from meta-analyses of Randomised Controlled Trials overall suggests that resistance training is likely to be a suitable intervention for persons with sarcopenic obesity, although the results may be suboptimal, in general.
- This is the first umbrella review on sarcopenic obesity conducted to provide comprehensive insights into the effectiveness of different nutrition and exercise interventions for adults.
- Four systematic reviews with between 30 to 225 participants were included in the umbrella review.
This systematic review and meta-analysis finds little evidence for or against recommending the dietary inclusion of legumes for the purpose of cardiovascular disease and type 2 diabetes prevention for healthy general populations.
- This study aimed to systematically review the evidence for associations between consumption of legumes and cardiovascular disease, type 2 diabetes and their risk factors among healthy adults using both observational and intervention studies.
- Findings from observational studies (generally with low legume consumption) did not support an association, although clinical trials did indicate some likely beneficial (although clinically small) effects on blood lipids and fasting glucose.
Using linear and non-linear Mendelian randomization analyses, this one suggests that a higher adiposity, as measured by BMI, is causally associated with an increased risk for rheumatic disease, an effect that is more pronounced in women for both gout and psoriatic arthropathy.
- A genetic predisposition to high BMI is was found to be causally linked to a higher risk of developing psoriatic arthropathy and inflammatory spondylitis.
- For psoriatic arthropathy and gout, sex-specific effects were observed, and for osteoarthritis, the effect of BMI was stronger in premenopausal compared to postmenopausal women.